BSECompany Update6 Aug 2026 · 6 Aug 2026, 06:03 pm

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Medplus Health Services Ltd · 543427

✦ AI Summary▼ NegativeRegulatory

Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses at stores in Karnataka, resulting in potential revenue loss of Rs 0.24 lacs, Rs 0.17 lacs, and Rs 0.23 lacs respectively.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

7927d162-cfac-4d05-b066-d2abd054f34f.pdf

pdf

Download →
View document text
MedPlus Health Services Limited August 06, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received three suspension orders for a Drug License of a store situated at below mentioned states: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Nature and details of the Date of receipt Details of the Impact on Authority action(s) taken, initiated or of direction or violation(s)/ financial order(s) passed order, including contravention(s) operation or any interim or committed or other activities of interim orders, alleged to be the listed entity, or any other committed quantifiable in communication monetary terms from the to the extent authority possible Suspension of Drug License Potential Revenue Assistant Director, Drugs for one day of store situated Loss of Rs 0.24 Control Administration, at Ashram Road Vijayapura, lacs. Vijayapura Circle, Karnataka. Under Rule 65 of Vijayapura, Karnataka. Suspension of Drug License Order received Potential Revenue Drugs and Cosmetics for one day of store situated on 05.08.2026 Loss of Rs 0.17 Act, 1940 and Drugs at Sindagi, Karnataka. lacs. and Cosmetics Rules, Assistand Director, Suspension of Drug License Potential Revenue 1945 Drugs Control for one day of store situated Loss of Rs 0.23 Administration, Raichur at Hanuman Talkies Road, lacs. Circle, Raichur, Karnataka. Karnataka. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer (M. No. F12400) 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com